SURFACTANT EFFECTS ON MORTALITY AND MORBIDITY OF RESPIRATORY DISTRESS SYNDROME IN NEONATES

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

KAMRANI K.; NASIRI KALMARZI R.; SOTOUDEH K.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Pediatrics Year:2008 | Volume:18 | Issue:1 (SUPPLEMENT) Page(s): 65-70

Download Full-Text

Persian Verion

View:

3,971

Download:

Cites:

Information Journal Paper

Title

SURFACTANT EFFECTS ON MORTALITY AND MORBIDITY OF RESPIRATORY DISTRESS SYNDROME IN NEONATES

Author(s)

KAMRANI K. | NASIRI KALMARZI R. | SOTOUDEH K. | | Issue Writer Certificate

Keywords

PREMATURITYQ3

RESPIRATORY DISTRESS SYNDROMEQ3

SURFACTANTQ3

NEONATEQ3

Abstract

Objective: The purpose of this study was to compare the mortality and morbidity rates of neonatal RESPIRATORY DISTRESS SYNDROME (RDS) treated with and without SURFACTANT in ventilated patients. Methods: In this descriptive-analytical study, the morbidity and mortality rates of RDS in 50 patients of the study group treated with SURFACTANT were compared with 66 patients of control group treated without SURFACTANT. The children of the control group received treatment at a time when SURFACTANT was not available in market. SURFACTANT was used as Survanta during the first 24 hours of life with a dose of 4 ml/kg in four different positions through tracheal tube only once. Findings: The two groups were comparable in baseline parameters including birth weight, sex, gestational age and primary diagnosis. Mortality reduced significantly. There were no differences in the incidence of severe complications including, intraventricular hemorrhage and patent ductus arteriosus, but pneumothorax, sepsis and pulmonary hemorrhage occurred more common in the control group.Conclusion: Use of SURFACTANT in neonatal RESPIRATORY DISTRESS SYNDROME significantly decreased mortality, pneumothorax, sepsis and pulmonary hemorrhage.

Cites

No record.

References

No record.

Cite

APA: Copy

KAMRANI, K., NASIRI KALMARZI, R., & SOTOUDEH, K.. (2008). SURFACTANT EFFECTS ON MORTALITY AND MORBIDITY OF RESPIRATORY DISTRESS SYNDROME IN NEONATES. IRANIAN JOURNAL OF PEDIATRICS, 18(1 (SUPPLEMENT)), 65-70. SID. https://sid.ir/paper/76006/en

Vancouver: Copy

KAMRANI K., NASIRI KALMARZI R., SOTOUDEH K.. SURFACTANT EFFECTS ON MORTALITY AND MORBIDITY OF RESPIRATORY DISTRESS SYNDROME IN NEONATES. IRANIAN JOURNAL OF PEDIATRICS[Internet]. 2008;18(1 (SUPPLEMENT)):65-70. Available from: https://sid.ir/paper/76006/en

IEEE: Copy

K. KAMRANI, R. NASIRI KALMARZI, and K. SOTOUDEH, “SURFACTANT EFFECTS ON MORTALITY AND MORBIDITY OF RESPIRATORY DISTRESS SYNDROME IN NEONATES,” IRANIAN JOURNAL OF PEDIATRICS, vol. 18, no. 1 (SUPPLEMENT), pp. 65–70, 2008, [Online]. Available: https://sid.ir/paper/76006/en

Related Journal Papers